RAJTHANEE HOSPITAL PUBLIC COMPANY LIMITEDSET: RJH🇹🇭 TH

Board Performance · 2024

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The Company monitors, manages, and addresses potential conflicts of interest that may arise between the Company and the management, the Board of Directors, or shareholders, including the prevention of misuse of assets, information, and opportunities, as well as engaging in inappropriate transactions. The Company has established a policy requiring the Board of Directors, executives, and employees to act in the best interests of the Company. In the event that any person has an interest or involvement in a matter under consideration, such person shall notify the secretary to keep a record of the disclosure of interests reported by the director or executive. This information will be used to monitor and supervise conflicts of interest.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The Company has policies and procedures to oversee directors and executives in using the Company's inside information, which has not yet been disclosed to the public, for personal gain, including securities trading, as follows: • Provide knowledge to directors and executives of various departments regarding their duty to report their shareholding, as well as that of their spouse and unemancipated children, to the Securities and Exchange Commission and the Stock Exchange of Thailand under Section 59 and the penalty provisions under Section 59 and Section 275 of the Securities and Exchange Act B.E. 2535.

• Directors and executives are required to report changes in their shareholding to the Securities and Exchange Commission according to Section 59 of the Securities and Exchange Act B.E. 2535 within 3 business days from the date of the change and to submit a copy of this report to the Company on the same day as the report is submitted to the Securities and Exchange Commission.

• The Company requires directors, executives, and relevant employees who are aware of material inside information that may affect the securities price to refrain from trading the Company's securities for at least 30 days prior to the public disclosure of such information and for at least 24 hours after the public disclosure. They are also prohibited from disclosing such material information to others.

• The Company shall impose disciplinary actions for any violation of using inside information for personal gain, ranging from a written reprimand, salary deduction, temporary suspension without pay, or dismissal. The penalty will be considered based on the intention of the act and the severity of the offense.

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

The Company places great importance on combating fraud and corruption, bribery, and encourages personnel at all levels to be aware of and combat fraud and corruption in all forms. The Company has established guidelines for the prevention of and participation in combating fraud and corruption as follows:

1. Declaration of Anti-Corruption Policy: The Company has a policy of combating fraud and corruption by establishing written guidelines, which are specified in the document "Hospital Rules and Regulations," and has communicated them to the Board of Directors, executives, and employees for their acknowledgement and implementation. In addition, this topic is included in the orientation of all new employees to ensure that they are aware of and strictly adhere to it. If a company employee commits fraud and corruption, it is considered a disciplinary offense resulting in termination of employment.

2. Fraud and Corruption Risk Assessment

• The Board of Directors has prepared a risk register for the Company according to the level of risk that occurs in order to plan for internal audits and manage operational risks that may arise.

• Conduct internal audits according to the established risk assessment plan by assigning internal auditors from external firms with experience and appropriate qualifications to comply with regulations and laws for efficient and transparent operations, which must be coordinated with the Company's Audit Committee.

3. Control and Prevention of Fraud and Corruption Risks

• The Company has established regulations for procurement, hiring, contracting, and disbursement, specifying authorization limits and the purpose of each transaction, which must be accompanied by clear supporting documents and a system of verification by experienced internal auditors with appropriate qualifications.

• Establish an internal control system covering finance, accounting, data recording, and other related internal processes in finance and accounting to ensure that such financial transactions are for the authorized purposes and for transparent business operations.

• Donations to charities or public support must be for charitable purposes only and must be supported by clear documentation and must be carried out in accordance with the Company's rules and regulations.

• The giving, offering, or accepting of gifts and entertainment must be transparent, legal, in accordance with normal business practices or customs, and of an appropriate value.

4. Reporting Fraud and Corruption Risks: The Company's directors, executives, and employees are required to report to the Company any acts that may constitute fraud and corruption related to the Company by notifying their supervisors and cooperating in verifying the facts.

5. Fraud and Corruption Risk Mitigation and Management: The Company's Audit Committee is responsible for monitoring and reviewing the Company's good corporate governance, which is in line with the Hospital's anti-corruption policy and relevant laws. If the Audit Committee discovers or suspects any item or action that may affect the transparency of the Company's operations, the Audit Committee has the independence to report its findings to the Board of Directors or the Management Committee for timely corrective action. If the Board of Directors, executives, or employees violate or fail to comply with the Company's policies, or commit any misconduct in accordance with their position, the Company will consider appropriate actions or measures against such individuals, ranging from disciplinary action in accordance with the regulations stipulated in the Company's regulations to legal action.

6. Protection of Whistleblowers: The Company will be fair and protect whistleblowers of fraud and corruption, as well as those who cooperate in reporting and investigating fraud and corruption, in order to prevent potential impacts on whistleblowers that are beneficial to the Company.

Form of Anti-Corruption Operations

Operation
Review of appropriateness in anti-corruption
Communication and training for employees on anti-corruption policy and guidelines
Review of the completeness and adequacy of the process by the Audit Committee or auditor

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The company has channels for complaints and suggestions. Complaints and suggestions can be submitted through the following channels:

1. By registered mail, addressed to the designated recipient for reporting at the address below, without specifying the sender's name.

Address: "Rajthanee Hospital Public Company Limited, 111 Moo 3, Rojana Road, Khlong Suan Phlu Subdistrict, Phra Nakhon Si Ayutthaya District, Phra Nakhon Si Ayutthaya Province 13000"

2. By email, suggestions or complaints can be sent to CS@rajthanee.com

After receiving a complaint, the management or related persons will investigate the facts to find a conclusion to resolve the issue as soon as possible. There are measures in place to protect complainants from any impact arising from the complaint.

Whistleblower Protection The RJH Group will provide fairness and protection to whistleblowers of fraud and corruption, including those who cooperate in reporting and in the investigation process, to prevent potential impacts on whistleblowers that benefit the company.

1. All complainants, whistleblowers, and witnesses will be protected. The names of whistleblowers and witnesses will not be disclosed to anyone. Only the complaint recipient, the Chairman of the Board of Directors, or the Chairman of the Audit Committee and the Company's Audit Committee will be aware.

2. The Company will provide protection and will not tolerate any intimidation or threats against employees who have filed complaints or reported misconduct and fraud, including those who cooperate or assist in investigations in good faith.

3. In the event that an employee is intimidated or threatened, they must immediately notify a trusted supervisor at any level to provide appropriate protection. This depends on the severity and importance of the complaint.

4. The Board of Directors, employees, or executives of the RJH Group are prohibited from terminating, suspending, disciplining, or threatening to take any action against employees for filing complaints or reporting misconduct or fraud.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Selection — Introduction

In appointing directors, the Nomination and Remuneration Committee, consisting of three independent directors and directors, is responsible for considering, selecting, and screening, recruiting individuals who are fully qualified, suitable according to the company's regulations, knowledgeable, capable, diverse, and experienced to benefit the company's operations. The committee utilizes the Director Pool database for recruitment considerations, taking into account the structure and composition of the Board of Directors. Recommendations are then presented to the Board of Directors for approval. Subsequently, the list of nominated directors is proposed to the shareholders' meeting following the criteria and procedures stipulated in the company's Articles of Association and relevant legal requirements.

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Rights of Minority Shareholders on Director Appointment

The Company recognizes and places importance on the fundamental rights of shareholders, both as owners of the Company and as investors in securities, such as the right to buy, sell, or transfer their securities, the right to receive adequate information from the Company, the right to receive dividends from the Company, various rights at the shareholders' meeting, the right to express opinions, the right to participate in making decisions on important matters of the Company, such as dividend allocation, appointment or removal of directors, appointment of auditors, approval of significant transactions that affect the Company's business direction, etc.

The Company will provide equal opportunities to all shareholders and stipulate that the voting rights at the meeting are in accordance with the number of shares held. One share is entitled to one vote and the Company will not undertake any action that restricts, violates, or deprives the rights of shareholders, whether they are major shareholders, minority shareholders, institutional investors, or foreign shareholders. The Company appoints independent directors to be responsible for overseeing minority shareholders. Minority shareholders can make suggestions, express opinions, or file complaints to the independent directors, who will consider appropriate actions for each matter. For example, in the case of complaints, the independent directors will conduct fact-finding and find appropriate solutions. In the case of suggestions that are important and affect the overall stakeholders or the Company's business operations, the independent directors will propose such matters to the shareholders' meeting for consideration to be included as an agenda item at the shareholders' meeting, etc.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

The Board of Directors will jointly consider the qualifications of persons to serve as independent directors by considering the qualifications and prohibited characteristics of directors under the Public Limited Company Act, the notifications of the Capital Market Supervisory Board, including relevant announcements, regulations and/or rules. The Board of Directors will consider selecting independent directors from qualified individuals, work experience, and other relevant suitability. The Board will then propose to the shareholders' meeting for consideration and appointment as directors of the company. The company has a policy of appointing at least 1 out of 3 independent directors of the total number of directors and must have no less than 3 persons. In addition, the Board Charter stipulates that the Board of Directors shall have independent directors serve for a continuous period of no more than 9 years from the date of their first appointment as independent directors.


Qualifications of Independent Directors are as follows:

1. Hold no more than 1 percent of the total voting shares of the company, parent company, subsidiary, affiliated company, major shareholder or person with control. This includes the shareholding of those related to such independent directors.

2. Not be or have been a director involved in management, employee, staff, salaried consultant, or person with control of the company, parent company, subsidiary, affiliated company, major shareholder, or person with control, unless such person has ceased to have such characteristics for at least 2 years. However, such prohibited characteristics do not include cases where the independent director was a government official or an advisor to a government agency that is a major shareholder or person with control of the company.

3. Not be a person who has a blood relationship or by registration under the law as a father, mother, spouse, sibling, and child, including the spouse of a child of the executive, major shareholder, or person with control of the company or a person who will be offered to be an executive or a person with control of the company or subsidiary.

4. Does not have or has had a business relationship with the company, parent company, subsidiary, or affiliated company, major shareholder, or person with control of the company in a manner that may interfere with the exercise of their independent judgment, and is not or has not been a significant shareholder or person with control of a person who has a business relationship with the company, parent company, subsidiary, affiliated company, major shareholder, or person with control of the company, unless such person has ceased to have such characteristics for at least 2 years.

5. Not be or have been an auditor of the company, parent company, subsidiary, affiliated company, major shareholder, or person with control of the company, and is not a significant shareholder, person with control, or partner of an audit firm to which the auditor of the company, parent company, subsidiary, affiliated company, major shareholder, or person with control of the company belongs, unless such person has ceased to have such characteristics for at least 2 years.

6. Not be or have been a professional service provider, including providing legal or financial advisory services, who has received a service fee of more than 2 million baht per year from the company, parent company, subsidiary, affiliated company, major shareholder, or person with control of the company, and is not a significant shareholder, person with control, or partner of such professional service provider, unless such person has ceased to have such characteristics for at least 2 years.

7. Not be a director appointed to represent a director of a major shareholder or a shareholder who is related to a major shareholder.

8. Have no other characteristics that would prevent them from providing independent opinions on the Company's operations.

See details about the composition, structure, qualifications, term of office, appointment and removal of directors, roles, duties, responsibilities and powers of the Board of Directors and the Chairman of the Board, meetings, quorums, and voting, including criteria, compensation. More information can be found on the company's website under "Corporate Governance".

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Qualifications for Director Selection — Introduction

The Nomination and Remuneration Committee has considered the nature of the business and future plans and has therefore determined the qualifications of the directors, taking into account the following elements:

1. Desired characteristics of each director. The Nomination and Remuneration Committee should consider and determine the individual characteristics of the persons to be selected for nomination as directors in various aspects, such as integrity and responsibility, data-driven and reasoned decision-making, maturity and stability, being a good listener and daring to express opinions professionally, and other characteristics that the Nomination and Remuneration Committee deems important.

2. Desired expertise on the Board. The Nomination and Remuneration Committee should consider determining the composition of the specific expertise required on the Board to enable the Board to effectively formulate strategies and policies, as well as oversee the implementation of such policies.

3. Board diversity. The Nomination and Remuneration Committee may consider guidelines on the diversity of other qualifications of the Board as a whole, such as age, knowledge, skills, experience in both Hard Skills and Soft Skills (Board Skill Matrix) to determine the qualifications of the directors to be recruited by considering the necessary skills that are still lacking in the Board and the company's business strategies. In addition, the Nomination and Remuneration Committee uses the expertise of the Board of Directors to consider the recruitment of directors to replace those whose terms expire, categorized into 3 areas:

3.1 Knowledge, expertise, or experience in macro-management, divided into various aspects such as business or industry related to the company, corporate management, human resource management in the public or private sector, economics, investment, including policy setting and strategic planning in marketing or public relations, international affairs, and risk management.

3.2 Specific knowledge, experience, or expertise, divided into 3 areas:

1) Legal aspects, regulations related to business operations

2) Accounting and finance, with knowledge and understanding of financial statements, accounting standards, or being/having been an auditor of a listed company.

3) Healthcare, real estate, to provide a dimension of diversity, support the entire Board of Directors to be complete, perfect, and effective, which is beneficial to the most efficient work.

3.3 Knowledge, expertise, or experience in corporate governance, divided into 2 areas:

1) Corporate governance, including the establishment of relevant policies and practices.

2) Treatment of various stakeholder groups.

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

The Company has established an annual evaluation of the Board of Directors and sub-committees, which is conducted in 3 formats:

1. Annual performance evaluation of the Board of Directors as a whole

The Board of Directors shall have in place an assessment of the performance of the Board of Directors as a whole, divided into 3 areas:

1) Roles, duties and responsibilities of the Board of Directors

2) Independence of the Board of Directors

3) Relationship with management and stakeholders

2. Annual performance evaluation of individual directors

The Board of Directors shall have in place an individual performance evaluation of each director, divided into 3 areas:

1) Roles, duties and responsibilities of the Board of Directors

2) Duties of the Board of Directors

3) Director Development

3. Annual performance evaluation of sub-committees. The Board of Directors shall have in place a performance evaluation of each sub-committee, with each member of the sub-committee evaluating the overall performance of the sub-committee on which he/she serves.

At the end of each year, the Company Secretary will send an evaluation form to all directors for self-evaluation and evaluation of each sub-committee. The results of the evaluation will be compared and used as information for further development.

Evaluation of Board Performance in the Past Year

For the year 2567, the performance evaluation results of the Board of Directors and sub-committees are as follows:

1. The performance evaluation results of the Board of Directors as a whole are 85.21 percent.

2. The self-assessment results of the individual Board of Directors are 89.09 percent.

3. The performance evaluation results of the sub-committees are 86.52 percent.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorY85.21100Y89.09100N

Subcommittees

Subcommittees

Results of the Subcommittee's Duty Performance

The Nomination and Remuneration Committee supports the Company's operations in recruiting and selecting directors with qualifications that align with the Company's business strategies, evaluating performance, and considering appropriate remuneration for directors. In 2024, the Nomination and Remuneration Committee held a total of 2 meetings, with full attendance by the committee members, representing 100% attendance. The committee has performed its duties as stipulated in the Nomination and Remuneration Committee Charter and as assigned by the Board of Directors. The key highlights of the committee's performance in 2024 are as follows:


1. Review the structure of the Board of Directors, including the Nomination and Remuneration Committee Charter, to ensure that the guidelines for performing duties are appropriate for business operations and aligned with the current situation.

2. Review and update the succession planning policy to ensure readiness in recruiting and selecting qualified personnel in line with the strategic management direction and to appropriately replace key positions or core jobs that will be vacated due to retirement or other reasons in the future.

3. Consider reviewing the annual performance evaluation form to align with the structure of the Board of Directors and sub-committees. This will provide a framework for performance reviews and data for improving operational efficiency.

Meeting Attendance & Remuneration

Justification for Directors' Non-Attendance

1. Ms. Pitcharampa Prasitthirun has been appointed as a director to replace the resigned director on November 12, 2023.

2. Dr. Thanathip Suphapradist resigned from his position on October 9, 2023.

Types of Remuneration of the Board of Directors

The company has established remuneration for directors and executives at an appropriate level and comparable to companies in the same industry. Factors considered include duties, scope, roles, and responsibilities. The remuneration of directors is subject to approval by the shareholders' meeting. Executive remuneration follows the principles and policies set by the Board of Directors, which considers the duties, responsibilities, and performance of each executive, as well as the company's overall performance. This information is presented in the Corporate Governance Structure and Key Information Regarding the Board of Directors, Subcommittees, Management, Employees, and Others, under the heading "Total Remuneration of Directors and Executives."

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

Directors or executives representing the Company must ensure that subsidiaries disclose transactions between such subsidiaries and their related persons, the acquisition and disposal of assets, or any other material transactions of such subsidiaries accurately, completely, and using the same criteria related to information disclosure and such transactions as the Company's criteria. This includes ensuring that subsidiaries prepare complete, accurate, and auditable financial statements and complete them on time.

In overseeing subsidiaries, the Board of Directors of the parent company is the one who approves the individuals to hold director positions in those subsidiaries.

In addition, the Company has a policy to appoint independent auditors to audit the operations of subsidiaries to prevent errors and to ensure transparency in operations as necessary and appropriate. The audit is conducted periodically, and a report is prepared and submitted to the Audit Committee for consideration.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies
Disclosure of financial information and operating results
Transactions between the Company and related persons
Other important transactions
Acquisition or disposal of assets
Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business

Agreements Between the Company and Shareholders in Managing Subsidiaries

The Company prepares a report on intercompany transactions that occurred during the year between the Company, its subsidiaries, and individuals/juristic persons with potential conflicts of interest. The Audit Committee reviewed the intercompany transactions or transactions with potential conflicts of interest that fall under the category of connected transactions according to the regulations of the Stock Exchange of Thailand and the Securities and Exchange Commission in 2024. The review of intercompany transactions conducted with related parties found that the Company had operated under normal commercial terms, which were fair, reasonable, and did not result in any transfer of benefits. The Company also disclosed complete and sufficient information, adhering to the principles of good corporate governance and the regulations of the Stock Exchange of Thailand.

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The Company conducts its business and management under the close supervision of the Board of Directors, with a commitment to conducting business with fairness and responsibility to all stakeholders under the principles of good corporate governance for listed companies 2017 by the Securities and Exchange Commission or Corporate Governance Code (CG Code) and the Company's Corporate Governance Policy and Code of Conduct to build confidence among shareholders, investors and stakeholders, create a good corporate culture and values, as well as support good business performance for the company, enhance competitiveness and sustainable growth.

In 2024, the Board of Directors reviewed the company's charter, policies, and practices in corporate governance according to the CG Code, including international best practices in corporate governance. Key examples of these practices are as follows:

• Review of good corporate governance policies and practices in accordance with the Company's Code of Conduct to plan for the recruitment and selection of qualified personnel in line with the strategic management direction to hold positions, replace key positions or core positions that will retire or become vacant in the future to ensure continuity of work and appropriate corporate management.

In addition to disclosing its CG Code compliance, the company also discloses its practices in other areas of good corporate governance, such as the Annual General Meeting Checklist (AGM Checklist) project, as well as enhancing ESG disclosures of listed companies to reflect business operations under good corporate governance that takes into account social and environmental impacts.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

Rajthanee Hospital Public Company Limited consists of 3 qualified independent directors with experience in law, accounting, and management, consisting of Ms. Sutthida Jirapatsakun as Chairman of the Audit Committee, Mr. Sutti Kittisupaporn and Mr. Adisorn Thavornthansan as Audit Committee members.

The Audit Committee of Rajthanee Hospital Public Company Limited has performed its responsibilities and expressed its independent opinions within the scope of authority assigned by the Board of Directors of Rajthanee Hospital Public Company Limited in accordance with the Audit Committee Charter, which is in line with the requirements of the Securities and Exchange Commission and the Stock Exchange of Thailand, including the review of financial statements, risk management, internal control system, compliance with laws, various rules and regulations related to business operations, intercompany transactions, and the consideration of the appointment of auditors and audit fees in 2024. The Audit Committee held a total of 4 meetings in 2024. The Audit Committee summarized the results of its operations in 2024, with the following key points:

1. Review of financial statements

2. Review of risk management

3. Review of internal control assessment

4. Review of corporate governance, compliance with relevant laws and regulations

5. Review of related party transactions or transactions that may have conflicts of interest

6. Consideration of the proposed appointment of auditors and audit fees for 2024

In conclusion, the Audit Committee's performance in 2024 has monitored the Company's operations by using its knowledge and ability, and has sufficient independence in accordance with the duties and responsibilities specified in the Audit Committee Charter. The Audit Committee is of the opinion that the Company has prepared financial statements that present material and reliable information in accordance with generally accepted accounting standards, with adequate disclosure of information, intercompany transactions, or transactions that may give rise to conflicts of interest. The Company has a good corporate governance system, a risk management system at an acceptable level, an internal control system sufficient for business operations, and complies with laws, regulations, and rules related to the Company's business operations.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

In 1984, the Executive Committee held a total of 12 meetings. The Committee performed its duties within the scope of authority, duties, and responsibilities stipulated in the Charter. In addition, the Executive Committee attended joint meetings with the management to monitor progress and provide advice to drive performance towards the established goals. The key operations of the Executive Committee include:


1. Collaborating with management in formulating policies, business strategies, goals, operational plans, financial targets, and budgets for the Company and its subsidiaries, taking into consideration industry and economic conditions, as well as social and technological changes that may impact the Company's business, for presentation and approval by the Board of Directors.

2. Overseeing the Company's business operations to align with policies, goals, operational plans, and financial targets, as well as monitoring the efficient and effective utilization of the budget approved by the Board of Directors to foster the growth of the company group.

3. Considering and providing feedback to management on organizational structuring, as well as defining guidelines and methodologies for setting annual performance indicators to promote and drive the achievement of the company group's goals.

4. Considering and providing recommendations to management on cash flow management to enhance return opportunities within an appropriate risk framework, ensuring that such investments comply with the investment policy approved by the Board of Directors, including managing risks arising from Thai baht volatility.

5. Considering and approving the Company's ordinary business transactions in accordance with the investment budget or budget approved by the Board of Directors. The funding for each transaction shall be in accordance with the authorized limit and the budget approved by the Board of Directors, including entering into related contracts.

Contents